Shizuo Narimatsu

3.5k total citations
162 papers, 3.0k citations indexed

About

Shizuo Narimatsu is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Shizuo Narimatsu has authored 162 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pharmacology, 59 papers in Oncology and 51 papers in Pharmacology. Recurrent topics in Shizuo Narimatsu's work include Pharmacogenetics and Drug Metabolism (100 papers), Drug Transport and Resistance Mechanisms (54 papers) and Cannabis and Cannabinoid Research (33 papers). Shizuo Narimatsu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (100 papers), Drug Transport and Resistance Mechanisms (54 papers) and Cannabis and Cannabinoid Research (33 papers). Shizuo Narimatsu collaborates with scholars based in Japan, Czechia and United States. Shizuo Narimatsu's co-authors include Hiroyuki Kataoka, Nobumitsu Hanioka, Hidetoshi Yoshimura, Ikuo Yamamoto, Shigeo Yamamoto, Kazuhito Watanabe, Shinsaku Naito, Janusz Pawliszyn, Heather Lord and Takanori Naito and has published in prestigious journals such as Analytical Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Shizuo Narimatsu

162 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shizuo Narimatsu Japan 27 1.1k 650 625 598 405 162 3.0k
Nobumitsu Hanioka Japan 29 1.3k 1.2× 235 0.4× 837 1.3× 953 1.6× 265 0.7× 144 3.3k
L. F. Chasseaud United States 25 723 0.7× 388 0.6× 340 0.5× 1.7k 2.9× 213 0.5× 162 3.9k
D. S. Davies United Kingdom 32 711 0.6× 246 0.4× 384 0.6× 801 1.3× 164 0.4× 93 3.2k
Richard M. Welch United States 34 836 0.8× 376 0.6× 269 0.4× 523 0.9× 123 0.3× 80 3.0k
J. Noordhoek Netherlands 32 960 0.9× 284 0.4× 667 1.1× 931 1.6× 162 0.4× 149 3.1k
Kwang‐Hyeon Liu South Korea 36 1.2k 1.0× 470 0.7× 473 0.8× 2.1k 3.4× 565 1.4× 188 4.8k
Eva Anzenbacherová Czechia 27 1.5k 1.4× 398 0.6× 795 1.3× 1.5k 2.5× 202 0.5× 98 3.6k
Urs A. Boelsterli Switzerland 45 2.4k 2.1× 817 1.3× 1.1k 1.8× 1.7k 2.9× 180 0.4× 110 5.3k
D. V. Parke United Kingdom 33 1.6k 1.4× 260 0.4× 620 1.0× 1.1k 1.9× 248 0.6× 148 4.1k
Risto O. Juvonen Finland 38 1.6k 1.4× 402 0.6× 784 1.3× 1.6k 2.6× 294 0.7× 120 4.4k

Countries citing papers authored by Shizuo Narimatsu

Since Specialization
Citations

This map shows the geographic impact of Shizuo Narimatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shizuo Narimatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shizuo Narimatsu more than expected).

Fields of papers citing papers by Shizuo Narimatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shizuo Narimatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shizuo Narimatsu. The network helps show where Shizuo Narimatsu may publish in the future.

Co-authorship network of co-authors of Shizuo Narimatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shizuo Narimatsu. A scholar is included among the top collaborators of Shizuo Narimatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shizuo Narimatsu. Shizuo Narimatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hattori, Yukiko, Yuji Ishii, Shizuo Narimatsu, et al.. (2015). Effect of <i>in utero</i> exposure to endocrine disruptors on fetal steroidogenesis governed by the pituitary-gonad axis: a study in rats using different ways of administration. The Journal of Toxicological Sciences. 40(6). 909–916. 16 indexed citations
2.
Hanioka, Nobumitsu, et al.. (2012). Stereoselective Glucuronidation of Carvedilol in Human Liver and Intestinal Microsomes. Pharmacology. 90(3-4). 117–124. 7 indexed citations
3.
Nishimura, Masuhiro, Akiko Koeda, Hiroshi Morikawa, et al.. (2008). Comparison of Inducibility of Multidrug Resistance (MDR)1, Multidrug Resistance-Associated Protein (MRP)1, and MRP2 mRNAs by Prototypical Microsomal Enzyme Inducers in Primary Cultures of Human and Cynomolgus Monkey Hepatocytes. Biological and Pharmaceutical Bulletin. 31(11). 2068–2072. 16 indexed citations
4.
Hanioka, Nobumitsu, Takanori Naito, & Shizuo Narimatsu. (2008). Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere. 74(1). 33–36. 115 indexed citations
5.
Saito, Keita, Kazufumi Masuda, Takashi Katsu, et al.. (2007). Stereoselective hexobarbital 3′‐hydroxylation by CYP2C19 expressed in yeast cells and the roles of amino acid residues at positions 300 and 476. Chirality. 19(7). 550–558. 5 indexed citations
6.
Nishimura, Masuhiro, Akiko Koeda, Emako Suzuki, et al.. (2006). Regulation of mRNA Expression of MDR1, MRP1, MRP2 and MRP3 by Prototypical Microsomal Enzyme Inducers in Primary Cultures of Human and Rat Hepatocytes. Drug Metabolism and Pharmacokinetics. 21(4). 297–307. 37 indexed citations
7.
Suzuki, Koichi, Tomotaka Tanabe, Tatsuya Funahashi, et al.. (2006). Identification and transcriptional organization of aerobactin transport and biosynthesis cluster genes of Vibrio hollisae. Research in Microbiology. 157(8). 730–740. 19 indexed citations
8.
Narimatsu, Shizuo, Shigeru Yamano, Yusuke Inoue, et al.. (2005). The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase. Chemico-Biological Interactions. 159(1). 47–57. 4 indexed citations
9.
Narimatsu, Shizuo, Takashi Isobe, Kazuo Asaoka, et al.. (2005). Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2. Chemico-Biological Interactions. 152(1). 1–12. 10 indexed citations
10.
Tanabe, Tomotaka, et al.. (2005). Identification of an AraC-like regulator gene required for induction of the 78-kDa ferrioxamine B receptor inVibrio vulnificus. FEMS Microbiology Letters. 249(2). 309–314. 29 indexed citations
11.
Narimatsu, Shizuo, Naoko Kobayashi, Kazuo Asaoka, et al.. (2001). High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol. Chirality. 13(3). 140–147. 8 indexed citations
12.
Kataoka, Hiroyuki, Toshiko Hayatsu, Herta Steinkellner, et al.. (2000). Identification of mutagenic heterocyclic amines (IQ, Trp-P-1 and AαC) in the water of the Danube River. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 466(1). 27–35. 50 indexed citations
13.
Cho, Arthur K., Shizuo Narimatsu, & Yoshito Kumagai. (1999). Metabolism of drugs of abuse by cytochromes P450. Addiction Biology. 4(3). 283–301. 7 indexed citations
14.
Narimatsu, Shizuo, et al.. (1996). Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats. Chemico-Biological Interactions. 101(3). 207–224. 7 indexed citations
15.
Masubuchi, Yasuhiro, et al.. (1994). Kinetic analysis of propranolol-induced impairment of its own metabolism in rats. Journal of Pharmacy and Pharmacology. 46(6). 528–530. 7 indexed citations
16.
17.
Narimatsu, Shizuo, Kazuhito Watanabe, Ikuo Yamamoto, & Hidetoshi Yoshimura. (1991). Sex difference in the oxidative metabolism of Δ9-tetrahydrocannabinol in the rat. Biochemical Pharmacology. 41(8). 1187–1194. 86 indexed citations
18.
Watanabe, Kazuhito, et al.. (1990). Comparison of pharmacological effects of tetrahydrocannabinols and their 11-hydroxy-metabolites in mice.. Chemical and Pharmaceutical Bulletin. 38(8). 2317–2319. 15 indexed citations
19.
Watanabe, Kazuhito, et al.. (1987). In vivo effects of tetrahydrocannabinols and their eight monooxygenated metabolites on the hepatic microsomal drug-metabolizing enzyme systems of mice.. Journal of Pharmacobio-Dynamics. 10(10). 580–586. 1 indexed citations
20.
Yamamoto, Ikuo, Shizuo Narimatsu, Kazuhito Watanabe, & Hidetoshi Yoshimura. (1982). 8α,9α-Epoxyhexahydrocannabinol formation from Δ8-tetrahydrocannabinol by mouse liver microsomes. Biochemical and Biophysical Research Communications. 109(3). 922–926. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobumitsu Hanioka Breakdown of academic impact, for papers by L. F. Chasseaud Breakdown of academic impact, for papers by D. S. Davies Breakdown of academic impact, for papers by Richard M. Welch Breakdown of academic impact, for papers by J. Noordhoek Breakdown of academic impact, for papers by Kwang‐Hyeon Liu Breakdown of academic impact, for papers by Eva Anzenbacherová Breakdown of academic impact, for papers by Urs A. Boelsterli Breakdown of academic impact, for papers by D. V. Parke Breakdown of academic impact, for papers by Risto O. Juvonen
Rankless by CCL
2026